Loading…
image

Report Scope & Overview:

Diabetes Management Devices Market Size was valued at $20.0 Billion in 2020 and is projected to reach $38.3 Billion by 2030, growing at a CAGR of 6.6% from 2021 to 2030.

Executive Summary:
The global Diabetes Management Devices market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.

The report provides a thorough analysis of the current demand and supply environment of the global Diabetes Management Devices market, as well as the price trends in the market for the next few years. The leading global players in the market are profiled, including their revenue, market share, profit margin, major product portfolio and SWOT analysis. The report also provides an analysis of the supply chain from an industry perspective, including an introduction to the process chart, upstream key raw material and cost analysis, distributor and downstream buyer analysis.

In addition, the report includes global and regional market size and forecasts, major product development trends, and typical downstream segment scenarios. The market drivers and inhibitors are analyzed in the context of these trends and scenarios. The report provides a comprehensive analysis of the market landscape, including competition analysis by price, revenue, sales, and market share by company, market rate, competitive situation landscape, and the latest trends, mergers, expansions, acquisitions, and market shares of top companies.

Diabetes Management Devices Market Key Trends

Continuous Glucose Monitoring (CGM) Advancements: Continuous Glucose Monitoring devices have seen significant technological advancements, with improvements in accuracy, ease of use, and connectivity. The trend is towards more real-time and comprehensive glucose monitoring to assist individuals in managing their diabetes effectively.

Insulin Delivery Systems: Advances in insulin delivery systems, including smart insulin pens and patch pumps, aim to enhance the precision and convenience of insulin administration. These devices often come with connectivity features, allowing users to track their insulin doses and share data with healthcare providers.

Integration of Artificial Intelligence (AI) and Machine Learning (ML): The integration of AI and ML technologies in diabetes management devices is becoming more prevalent. These technologies can analyze large datasets from continuous monitoring devices to provide personalized insights and predictions for better diabetes management.

Telemedicine and Digital Health Solutions: The growing use of telemedicine and digital health platforms for diabetes management has become especially prominent. Mobile apps, virtual coaching, and remote monitoring help individuals with diabetes and their healthcare providers track and manage the condition more effectively.

Wearable Devices and IoT Integration: Wearable devices that integrate with the Internet of Things (IoT) have gained popularity. Smartwatches and other wearables can now monitor glucose levels, physical activity, and other relevant health metrics, providing a holistic approach to diabetes management.

Patient-Centric Design: There is a growing emphasis on designing devices with a focus on user experience and patient preferences. User-friendly interfaces, smaller form factors, and devices that seamlessly integrate into daily life contribute to better patient adherence and engagement.

Market Segmentations:

Global Diabetes Management Devices Market: By Company
• Abbott Laboratories
• Dexcom
• Roche
• Lifescan
• Medtronic
• Terumo
• B. Braun Melsungen
• BD
• Ascensia (Bayer)
• Senseonics Holdings
• Johnson & Johnson
• Eli Lilly
• Novo Nordisk
• Sanofi
• Ypsomed Holding
• GlySens Incorporated
• Meiqi Medical Equipment
• San Meditech
• All Medicus

Global Diabetes Management Devices Market: By Type
• Blood Glucose Monitoring Device
• Insulin Delivery Systems

Global Diabetes Management Devices Market: By Application
• Hospitals
• Clinics
• Others


Global Diabetes Management Devices Market: Regional Analysis
The regional analysis of the global Diabetes Management Devices market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Diabetes Management Devices market report are as follows:

North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Diabetes Management Devices in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.

Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Diabetes Management Devices in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.

Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Diabetes Management Devices in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.

Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.

South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Diabetes Management Devices in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
Report Attribute/MetricDetails
Market Size 2020$20.0 Billion 
Market Size 2030$38.3 Billion
Compound Annual Growth Rate (CAGR)6.6%(2021-2030)
Base Year2022
Forecast Period2023-2032
Historical Data2018-2022
Forecast UnitsValue ($ Billion)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Blood Glucose Monitoring Device
• Insulin Delivery Systems
By Application• Hospitals
• Clinics
Key Companies Profiled• Abbott Laboratories
• Dexcom
• Roche
• Lifescan
• Medtronic
• Terumo
• B. Braun Melsungen
• BD
• Ascensia (Bayer)
• Senseonics Holdings
• Johnson & Johnson
• Eli Lilly
• Novo Nordisk
• Sanofi
• Ypsomed Holding
• GlySens Incorporated
• Meiqi Medical Equipment
• San Meditech
• All Medicus
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Diabetes Management Devices Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.

Objectives of Diabetes Management Devices Market Study:
The objectives of Diabetes Management Devices market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Diabetes Management Devices market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Diabetes Management Devices market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.

Frequently Asked Questions

FAQs not found for this report

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Management Devices Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Blood Glucose Monitoring Device
1.2.3 Insulin Delivery Systems
1.3 Market by Application
1.3.1 Global Diabetes Management Devices Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Management Devices Market Perspective (2017-2032)
2.2 Diabetes Management Devices Growth Trends by Region
2.2.1 Global Diabetes Management Devices Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Diabetes Management Devices Historic Market Size by Region (2017-2023)
2.2.3 Diabetes Management Devices Forecasted Market Size by Region (2023-2032)
2.3 Diabetes Management Devices Market Dynamics
2.3.1 Diabetes Management Devices Industry Trends
2.3.2 Diabetes Management Devices Market Drivers
2.3.3 Diabetes Management Devices Market Challenges
2.3.4 Diabetes Management Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Management Devices Players by Revenue
3.1.1 Global Top Diabetes Management Devices Players by Revenue (2017-2023)
3.1.2 Global Diabetes Management Devices Revenue Market Share by Players (2017-2023)
3.2 Global Diabetes Management Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Management Devices Revenue
3.4 Global Diabetes Management Devices Market Concentration Ratio
3.4.1 Global Diabetes Management Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Management Devices Revenue in 2022
3.5 Diabetes Management Devices Key Players Head office and Area Served
3.6 Key Players Diabetes Management Devices Product Solution and Service
3.7 Date of Enter into Diabetes Management Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Management Devices Breakdown Data by Type
4.1 Global Diabetes Management Devices Historic Market Size by Type (2017-2023)
4.2 Global Diabetes Management Devices Forecasted Market Size by Type (2023-2032)
5 Diabetes Management Devices Breakdown Data by Application
5.1 Global Diabetes Management Devices Historic Market Size by Application (2017-2023)
5.2 Global Diabetes Management Devices Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Diabetes Management Devices Market Size (2017-2032)
6.2 North America Diabetes Management Devices Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Diabetes Management Devices Market Size by Country (2017-2023)
6.4 North America Diabetes Management Devices Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Management Devices Market Size (2017-2032)
7.2 Europe Diabetes Management Devices Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Diabetes Management Devices Market Size by Country (2017-2023)
7.4 Europe Diabetes Management Devices Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Management Devices Market Size (2017-2032)
8.2 Asia-Pacific Diabetes Management Devices Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Diabetes Management Devices Market Size by Region (2017-2023)
8.4 Asia-Pacific Diabetes Management Devices Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Management Devices Market Size (2017-2032)
9.2 Latin America Diabetes Management Devices Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Diabetes Management Devices Market Size by Country (2017-2023)
9.4 Latin America Diabetes Management Devices Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Management Devices Market Size (2017-2032)
10.2 Middle East & Africa Diabetes Management Devices Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Diabetes Management Devices Market Size by Country (2017-2023)
10.4 Middle East & Africa Diabetes Management Devices Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Diabetes Management Devices Introduction
11.1.4 Abbott Laboratories Revenue in Diabetes Management Devices Business (2017-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Dexcom
11.2.1 Dexcom Company Detail
11.2.2 Dexcom Business Overview
11.2.3 Dexcom Diabetes Management Devices Introduction
11.2.4 Dexcom Revenue in Diabetes Management Devices Business (2017-2023)
11.2.5 Dexcom Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Diabetes Management Devices Introduction
11.3.4 Roche Revenue in Diabetes Management Devices Business (2017-2023)
11.3.5 Roche Recent Development
11.4 Lifescan
11.4.1 Lifescan Company Detail
11.4.2 Lifescan Business Overview
11.4.3 Lifescan Diabetes Management Devices Introduction
11.4.4 Lifescan Revenue in Diabetes Management Devices Business (2017-2023)
11.4.5 Lifescan Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Diabetes Management Devices Introduction
11.5.4 Medtronic Revenue in Diabetes Management Devices Business (2017-2023)
11.5.5 Medtronic Recent Development
11.6 Terumo
11.6.1 Terumo Company Detail
11.6.2 Terumo Business Overview
11.6.3 Terumo Diabetes Management Devices Introduction
11.6.4 Terumo Revenue in Diabetes Management Devices Business (2017-2023)
11.6.5 Terumo Recent Development
11.7 B. Braun Melsungen
11.7.1 B. Braun Melsungen Company Detail
11.7.2 B. Braun Melsungen Business Overview
11.7.3 B. Braun Melsungen Diabetes Management Devices Introduction
11.7.4 B. Braun Melsungen Revenue in Diabetes Management Devices Business (2017-2023)
11.7.5 B. Braun Melsungen Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Diabetes Management Devices Introduction
11.8.4 BD Revenue in Diabetes Management Devices Business (2017-2023)
11.8.5 BD Recent Development
11.9 Ascensia (Bayer)
11.9.1 Ascensia (Bayer) Company Detail
11.9.2 Ascensia (Bayer) Business Overview
11.9.3 Ascensia (Bayer) Diabetes Management Devices Introduction
11.9.4 Ascensia (Bayer) Revenue in Diabetes Management Devices Business (2017-2023)
11.9.5 Ascensia (Bayer) Recent Development
11.10 Senseonics Holdings
11.10.1 Senseonics Holdings Company Detail
11.10.2 Senseonics Holdings Business Overview
11.10.3 Senseonics Holdings Diabetes Management Devices Introduction
11.10.4 Senseonics Holdings Revenue in Diabetes Management Devices Business (2017-2023)
11.10.5 Senseonics Holdings Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Diabetes Management Devices Introduction
11.11.4 Johnson & Johnson Revenue in Diabetes Management Devices Business (2017-2023)
11.11.5 Johnson & Johnson Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Detail
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Diabetes Management Devices Introduction
11.12.4 Eli Lilly Revenue in Diabetes Management Devices Business (2017-2023)
11.12.5 Eli Lilly Recent Development
11.13 Novo Nordisk
11.13.1 Novo Nordisk Company Detail
11.13.2 Novo Nordisk Business Overview
11.13.3 Novo Nordisk Diabetes Management Devices Introduction
11.13.4 Novo Nordisk Revenue in Diabetes Management Devices Business (2017-2023)
11.13.5 Novo Nordisk Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Diabetes Management Devices Introduction
11.14.4 Sanofi Revenue in Diabetes Management Devices Business (2017-2023)
11.14.5 Sanofi Recent Development
11.15 Ypsomed Holding
11.15.1 Ypsomed Holding Company Detail
11.15.2 Ypsomed Holding Business Overview
11.15.3 Ypsomed Holding Diabetes Management Devices Introduction
11.15.4 Ypsomed Holding Revenue in Diabetes Management Devices Business (2017-2023)
11.15.5 Ypsomed Holding Recent Development
11.16 GlySens Incorporated
11.16.1 GlySens Incorporated Company Detail
11.16.2 GlySens Incorporated Business Overview
11.16.3 GlySens Incorporated Diabetes Management Devices Introduction
11.16.4 GlySens Incorporated Revenue in Diabetes Management Devices Business (2017-2023)
11.16.5 GlySens Incorporated Recent Development
11.17 Meiqi Medical Equipment
11.17.1 Meiqi Medical Equipment Company Detail
11.17.2 Meiqi Medical Equipment Business Overview
11.17.3 Meiqi Medical Equipment Diabetes Management Devices Introduction
11.17.4 Meiqi Medical Equipment Revenue in Diabetes Management Devices Business (2017-2023)
11.17.5 Meiqi Medical Equipment Recent Development
11.18 San Meditech
11.18.1 San Meditech Company Detail
11.18.2 San Meditech Business Overview
11.18.3 San Meditech Diabetes Management Devices Introduction
11.18.4 San Meditech Revenue in Diabetes Management Devices Business (2017-2023)
11.18.5 San Meditech Recent Development
11.19 All Medicus
11.19.1 All Medicus Company Detail
11.19.2 All Medicus Business Overview
11.19.3 All Medicus Diabetes Management Devices Introduction
11.19.4 All Medicus Revenue in Diabetes Management Devices Business (2017-2023)
11.19.5 All Medicus Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Dexcom
Roche
Lifescan
Medtronic
Terumo
B. Braun Melsungen
BD
Ascensia (Bayer)
Senseonics Holdings
Johnson & Johnson
Eli Lilly
Novo Nordisk
Sanofi
Ypsomed Holding
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
All Medicus
Request Sample